Not applicableStudy completedNCT02106858What this trial is testingStivarga Regulatory Post-Marketing Surveillance Study in KoreaWho this might be right forColorectal Neoplasms Bayer 316
Testing effectiveness (Phase 2)Active Not RecruitingNCT04117945What this trial is testingRegorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal CancerWho this might be right forBRAF V600E NegativeKRAS Gene Mutation NegativeLocally Advanced Unresectable Colorectal Adenocarcinoma+10 more Academic and Community Cancer Research United 22
Large-scale testing (Phase 3)Ended earlyNCT03970694What this trial is testingNeoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon CancerWho this might be right forColon Cancer Sun Yat-sen University 49
Testing effectiveness (Phase 2)Study completedNCT01040000What this trial is testingQUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal CancerWho this might be right forMetastatic Pancreatic CancerMetastatic Colorectal Cancer Precision Biologics, Inc 94
Testing effectiveness (Phase 2)Ended earlyNCT04844073What this trial is testingTAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic CancerWho this might be right forSquamous Cell Cancer of Head and Neck (SCCHN)Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer Takeda 95
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631884What this trial is testingExploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid TumorWho this might be right forSolid TumorsNeoplasms (Cancer / Tumors)Advanced Malignant Solid Neoplasm+13 more Haihua Yuan 15
Testing effectiveness (Phase 2)Study completedNCT00263029What this trial is testingPreoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal CancerWho this might be right forRectal Neoplasms Sanofi 18
Testing effectiveness (Phase 2)Ended earlyNCT05091528What this trial is testingA Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive CancersWho this might be right forHER2-positive Breast CancerHER2-positive Gastric CancerHER2-positive Colorectal Cancer+1 more Silverback Therapeutics 2
Testing effectiveness (Phase 2)Looking for participantsNCT06244771What this trial is testingA Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid TumorsWho this might be right forAdvanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more Frontier Medicines Corporation 403
Early research (Phase 1)Ended earlyNCT04627142What this trial is testingTest Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) MutationWho this might be right forMetastatic Colorectal Cancer (CRC) Boehringer Ingelheim 15
Testing effectiveness (Phase 2)Ended earlyNCT02010567What this trial is testingNeoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal CancerWho this might be right forRectal Cancer UNC Lineberger Comprehensive Cancer Center 32
Early research (Phase 1)Looking for participantsNCT07066657What this trial is testingMRG007 (ARR-217) in Patients With Advanced Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid TumorsColorectal CancerGastric Cancer+1 more ArriVent BioPharma, Inc. 572
Early research (Phase 1)Looking for participantsNCT06440005What this trial is testingEvaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsWho this might be right forCancerAdvanced CancerLocally Advanced Carcinoma+8 more Angiex, Inc. 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07509398What this trial is testingFMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal CancerWho this might be right forUnresectable Colorectal CancerColorectal Cancer (Locally Advanced or Metastatic) Shanghai 10th People's Hospital 220
Post-approval studies (Phase 4)Not Yet RecruitingNCT07446465What this trial is testingFOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal CancerWho this might be right forColorectal Cancer (Locally Advanced or Metastatic)Colorectal Cancer Microsatellite Stable (MSS) Ye Xu 42
Testing effectiveness (Phase 2)Looking for participantsNCT06682793What this trial is testingEvaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNon-Small Cell Lung+14 more A2 Biotherapeutics Inc. 240
Early research (Phase 1)Study completedNCT03821233What this trial is testingA Dose Finding Study of ZW49 in Patients With HER2-Positive CancersWho this might be right forHER2-expressing Cancers Zymeworks BC Inc. 112
Testing effectiveness (Phase 2)Looking for participantsNCT07488676What this trial is testingASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsWho this might be right forGastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma Astellas Pharma Global Development, Inc. 150
Early research (Phase 1)Ended earlyNCT06364696What this trial is testingFind a Suitable Dose of ASP4396 in Adults With Solid TumorsWho this might be right forSolid Tumor Astellas Pharma Inc 60
Testing effectiveness (Phase 2)Looking for participantsNCT06051695What this trial is testingEvaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNSCLC+17 more A2 Biotherapeutics Inc. 474